JP2022536797A5 - - Google Patents
Info
- Publication number
- JP2022536797A5 JP2022536797A5 JP2021574932A JP2021574932A JP2022536797A5 JP 2022536797 A5 JP2022536797 A5 JP 2022536797A5 JP 2021574932 A JP2021574932 A JP 2021574932A JP 2021574932 A JP2021574932 A JP 2021574932A JP 2022536797 A5 JP2022536797 A5 JP 2022536797A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025133519A JP2025172264A (ja) | 2019-06-18 | 2025-08-08 | 炎症性状態を処置するための方法および組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962862977P | 2019-06-18 | 2019-06-18 | |
| US62/862,977 | 2019-06-18 | ||
| PCT/US2020/038036 WO2020257221A1 (en) | 2019-06-18 | 2020-06-17 | Methods and compositions for treating inflammatory conditions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025133519A Division JP2025172264A (ja) | 2019-06-18 | 2025-08-08 | 炎症性状態を処置するための方法および組成物 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022536797A JP2022536797A (ja) | 2022-08-18 |
| JPWO2020257221A5 JPWO2020257221A5 (https=) | 2023-11-30 |
| JP2022536797A5 true JP2022536797A5 (https=) | 2023-11-30 |
| JP7818405B2 JP7818405B2 (ja) | 2026-02-20 |
Family
ID=74040112
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021574932A Active JP7818405B2 (ja) | 2019-06-18 | 2020-06-17 | 炎症性状態を処置するための方法および組成物 |
| JP2025133519A Withdrawn JP2025172264A (ja) | 2019-06-18 | 2025-08-08 | 炎症性状態を処置するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025133519A Withdrawn JP2025172264A (ja) | 2019-06-18 | 2025-08-08 | 炎症性状態を処置するための方法および組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220313780A1 (https=) |
| EP (2) | EP4461303A3 (https=) |
| JP (2) | JP7818405B2 (https=) |
| CN (1) | CN114258317B (https=) |
| AU (1) | AU2020295989A1 (https=) |
| WO (1) | WO2020257221A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120518705A (zh) * | 2025-07-23 | 2025-08-22 | 中国海洋大学 | 一种多肽类化合物及其制备方法和应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4965343A (en) | 1988-01-28 | 1990-10-23 | Hoffmann-La Roche Inc. | Method of peptide synthesis |
| US5849954A (en) | 1996-01-18 | 1998-12-15 | Research Corporation Technologies, Inc. | Method of peptide synthesis |
| US5892014A (en) * | 1996-10-30 | 1999-04-06 | The Regents Of The University Of California | DNA encoding a protease-activated receptor 3 |
| CN1308671A (zh) * | 1998-05-05 | 2001-08-15 | 科里克萨公司 | 髓磷脂碱性蛋白肽及其应用 |
| ATE281472T1 (de) | 1999-08-02 | 2004-11-15 | Synt Em Sa | Berechnungsmethoden zur herstellung von molekularen mimetika |
| US7271256B2 (en) | 2000-02-04 | 2007-09-18 | New England Biolabs, Inc. | Method for producing circular or multimeric protein species in vivo or in vitro and related methods |
| JP4798921B2 (ja) * | 2000-03-06 | 2011-10-19 | バイオシーク インコーポレーティッド | 機能相同性スクリーニング |
| US7696168B2 (en) * | 2000-04-21 | 2010-04-13 | Tufts Medical Center, Inc. | G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same |
| FR2841559A1 (fr) * | 2002-06-28 | 2004-01-02 | Pfizer | Recepteurs par modifies, preparation et utilisations |
| GB0224013D0 (en) * | 2002-10-15 | 2002-11-27 | Oxford Glycosciences Uk Ltd | A protein involved in therapy |
| WO2004056309A2 (en) * | 2002-12-05 | 2004-07-08 | Socratech L.L.C. | Neuroprotective activity of activated protein c is independent of its anticoagulant activity |
| AU2006242449A1 (en) | 2005-04-29 | 2006-11-09 | (Osi) Eyetech, Inc. | VEGF variants |
| US20080090760A2 (en) | 2005-12-09 | 2008-04-17 | Todd Hembrough | Compositions and Methods for Inhibiting Cellular Proliferation |
| CN101801462A (zh) * | 2007-07-13 | 2010-08-11 | 健泰科生物技术公司 | 用于癌症、炎性病症和自身免疫性病症的治疗和诊断 |
| WO2013070256A2 (en) * | 2011-11-07 | 2013-05-16 | The Scripps Research Institute | Protease activated receptor-1 (par1) derived cytoprotective polypeptides and related methods |
| CN104470943B (zh) * | 2012-07-03 | 2017-07-14 | 一洋药品株式会社 | 新肽及其用途 |
| WO2017173346A1 (en) * | 2016-04-01 | 2017-10-05 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Par3 mimetic peptides and uses thereof |
| CA3075833C (en) * | 2017-09-18 | 2024-06-11 | BH Biotech Pty Ltd | Composition comprising withania extract, omega-3 fatty acids and natural product extracts and uses thereof |
-
2020
- 2020-06-17 JP JP2021574932A patent/JP7818405B2/ja active Active
- 2020-06-17 AU AU2020295989A patent/AU2020295989A1/en active Pending
- 2020-06-17 WO PCT/US2020/038036 patent/WO2020257221A1/en not_active Ceased
- 2020-06-17 CN CN202080058199.7A patent/CN114258317B/zh active Active
- 2020-06-17 EP EP24184115.4A patent/EP4461303A3/en active Pending
- 2020-06-17 EP EP20826563.7A patent/EP3986560A4/en active Pending
- 2020-06-17 US US17/617,989 patent/US20220313780A1/en active Pending
-
2025
- 2025-08-08 JP JP2025133519A patent/JP2025172264A/ja not_active Withdrawn